Steven Teerenstra

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Juvenile Idiopathic Arthritis

Acute Kidney Injury

Systematic Review

Inflammatory Response

Top Venues

Journal of clinical medicine

Rheumatology advances in practice

Statistics in medicine

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Steven Teerenstra, Jessica Kasza, Ruslan Leontjevas, Andrew B Forbes
Sample size for partially nested designs and other nested or crossed designs with a continuous outcome when adjusted for baseline. Statistics in medicine (2023)
Clementine E M Verhulst, Julia I P van Heck, Therese W Fabricius, Rinke Stienstra, Steven Teerenstra, Rory J McCrimmon, Cornelis Cees J Tack, Ulrik Pedersen-Bjergaard, Bastiaan E De Galan, null null
Hypoglycaemia induces a sustained pro-inflammatory response in people with type 1 diabetes and healthy controls. Diabetes, obesity & metabolism (2023)
Paul J T Rood, Dharmanand Ramnarain, Annemarie W Oldenbeuving, Brenda Leontine Den Oudsten, Sjaak Pouwels, Lex M van Loon, Steven Teerenstra, Peter Pickkers, Jolanda de Vries, Mark van den Boogaard
The Impact of Non-Pharmacological Interventions on Delirium in Neurological Intensive Care Unit Patients: A Single-Center Interrupted Time Series Trial. Journal of clinical medicine 12 (18) (2023)
Clementine E M Verhulst, Therese W Fabricius, Steven Teerenstra, Peter Lommer Kristensen, Cornelis Cees J Tack, Rory J McCrimmon, Simon R Heller, Mark L Evans, Stephanie A Amiel, Ulrik Pedersen-Bjergaard, Bastiaan E De Galan, null null
Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review. Diabetologia 65 (10) (2022)
Anne M Schijvens, Nynke Teeninga, Eiske M Dorresteijn, Steven Teerenstra, Nicholas J A Webb, Michiel F Schreuder
Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis. European journal of pediatrics 180 (9) (2021)
Wieland D Müskens, Sanne A A Rongen-van Dartel, Steven Teerenstra, Eddy M M Adang, Piet L C M van Riel
One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology. Rheumatology advances in practice 4 (2) (2020)